Rodman & Renshaw downgrades Novavax (Nasdaq: NVAX) from Market Outperform to Market Perform.

Rodman analyst says, "We believe that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE